Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02843555 · ClinicalTrials.gov registry record
Natural History of the Leukodystrophies
A clinical trial of Leukodystrophies, sponsored by Baylor Research Institute.
- Completed
- Registry status
- 10
- Enrollment target
- 1
- Study location
NCT02843555: Completed study of Leukodystrophies, sponsored by Baylor Research Institute.
NCT02843555 is a study of Leukodystrophies that has completed, run by Baylor Research Institute. The registered enrollment target is 10 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02843555, a study of Leukodystrophies, has completed, sponsored by Baylor Research Institute.
- COMPLETED
- Registry status
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to: 1. define novel homogeneous groups of patients with LDs and 2. work toward finding the cause of these disorders.
Primary Outcome
Neuropsychological status is evaluated at Baseline and no less than once every year for the duration of the study to assess for any deterioration in function
Conditions Studied
Study Locations (1)
Texas
- Baylor University Medical Center - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2019-01-23 |
| Est. Completion | 2019-01-23 |
What the finished NCT02843555 record still lists
NCT02843555 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 10 participants, a relatively small participant target.
The record links to 1 condition, with Leukodystrophies appearing as the primary indexed condition, and to 0 interventions.
NCT02843555 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT02843555 about?
NCT02843555 is a clinical study titled "Natural History of the Leukodystrophies". The purpose of this study is to: 1. define novel homogeneous groups of patients with LDs and 2. work toward finding the cause of these disorders.
What is the current status of trial NCT02843555?
This trial is currently completed. The enrollment target is 10 participants. The study started on 2019-01-23. Estimated completion is 2019-01-23.
What conditions does trial NCT02843555 study?
This clinical trial studies the following conditions: Leukodystrophies.
Who is sponsoring clinical trial NCT02843555?
This trial is sponsored by Baylor Research Institute, which has 180 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02843555 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI